Literature DB >> 8251586

Immune effector role of macrophages in experimental schistosomiasis mansoni.

S L James1, D L Boros.   

Abstract

Entities:  

Mesh:

Year:  1994        PMID: 8251586

Source DB:  PubMed          Journal:  Immunol Ser        ISSN: 0092-6019


× No keyword cloud information.
  5 in total

1.  Developmental differences determine larval susceptibility to nitric oxide-mediated killing in a murine model of vaccination against Schistosoma mansoni.

Authors:  S F Ahmed; I P Oswald; P Caspar; S Hieny; L Keefer; A Sher; S L James
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

Review 2.  Interleukin-12 in infectious diseases.

Authors:  L Romani; P Puccetti; F Bistoni
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

3.  Cross-reactivity of Schistosoma mansoni cytosolic superoxide dismutase, a protective vaccine candidate, with host superoxide dismutase and identification of parasite-specific B epitopes.

Authors:  Claudia Carvalho-Queiroz; Rosemary Cook; Ching C Wang; Rodrigo Correa-Oliveira; Nicola A Bailey; Nejat K Egilmez; Edith Mathiowitz; Philip T LoVerde
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

Review 4.  Role of nitric oxide in parasitic infections.

Authors:  S L James
Journal:  Microbiol Rev       Date:  1995-12

5.  Inducible nitric oxide synthase-deficient mice develop enhanced type 1 cytokine-associated cellular and humoral immune responses after vaccination with attenuated Schistosoma mansoni cercariae but display partially reduced resistance.

Authors:  S L James; A W Cheever; P Caspar; T A Wynn
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.